Jpmorgan Chase & CO Aziyo Biologics, Inc. Transaction History
Jpmorgan Chase & CO
- $1.14 Trillion
- Q2 2024
A detailed history of Jpmorgan Chase & CO transactions in Aziyo Biologics, Inc. stock. As of the latest transaction made, Jpmorgan Chase & CO holds 29 shares of AZYO stock, worth $42. This represents 0.0% of its overall portfolio holdings.
Number of Shares
29
Previous 24
20.83%
Holding current value
$42
Previous $0
NaN%
% of portfolio
0.0%
Previous 0.0%
Shares
4 transactions
Others Institutions Holding AZYO
# of Institutions
28Shares Held
9.06MCall Options Held
893KPut Options Held
0-
Nantahala Capital Management, LLC New Canaan, CT1.8MShares$2.6 Million0.17% of portfolio
-
Aigh Capital Management LLC Baltimore, MD1.7MShares$2.46 Million0.89% of portfolio
-
Silverarc Capital Management, LLC1.6MShares$2.33 Million0.66% of portfolio
-
Birchview Capital, LP Burlington, VT1.55MShares$2.25 Million2.25% of portfolio
-
Perkins Capital Management Inc857KShares$1.24 Million1.22% of portfolio
About AZIYO BIOLOGICS, INC.
- Ticker AZYO
- Exchange NASDAQ
- Sector Healthcare
- Industry Medical Devices
- Shares Outstandng 9,308,720
- Market Cap $13.5M
- Description
- Aziyo Biologics, Inc., a regenerative medicine company, focuses on the development of regenerative medical products to address the implantable electronic device/cardiovascular, orthopedic/spinal repair, and soft tissue reconstruction markets. It offers CanGaroo that combines the envelope with antibiotics and is designed to reduce the risk of inf...